Publication | Closed Access

Epigallocatechin-3-gallate prevents inflammation and diabetes -Induced glucose tolerance through inhibition of NLRP3 inflammasome activation

InflammationMetabolic SyndromeGlucose ToleranceAnti-inflammatoryMedicineDiabetesImmunologyCell DeathChronic InflammationNlrp3 Inflammasome ActivationDiabetes MellitusEpigallocatechin-3-gallate Prevents InflammationPharmacologyCell BiologyCell SignalingOxidative Stress